GSK Partners in Combinatorial Stem-Cell Technology
By
GlaxoSmithKline (GSK) and Plasticell, a biotechnology company using combinatorial cell-culture technologies for optimization of cell and gene-therapy manufacturing, have signed a pact to optimize induced pluripotent stem cells (iPSCs) differentiation…
AbbVie, Harpoon Therapeutics in Immuno-Oncology Pact
By
AbbVie and Harpoon Therapeutics, a biotechnology company developing T-cell recruiting biologic therapies, have formed an immuno-oncology research collaboration. The goal of the collaboration is to incorporate Harpoon’s tri-specific T-cell activating…